I
Ina M. Ott
Researcher at University of Potsdam
Publications - 2
Citations - 193
Ina M. Ott is an academic researcher from University of Potsdam. The author has contributed to research in topics: Telmisartan & Diabetic nephropathy. The author has an hindex of 2, co-authored 2 publications receiving 175 citations.
Papers
More filters
Journal ArticleDOI
DPP-4 Inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy
Markus Alter,Ina M. Ott,Karoline von Websky,Oleg Tsuprykov,Yuliya Sharkovska,Katharina Krause-Relle,Jens Raila,Andrea Henze,Thomas Klein,Berthold Hocher +9 more
TL;DR: DPP-4 inhibition on top of ARB treatment significantly reduced urinary albumin excretion and oxidative stress in diabetic eNOS knockout mice and may offer a new therapeutic approach for patients with diabetic nephropathy.
Journal ArticleDOI
Effects of Stimulation of Soluble Guanylate Cyclase on Diabetic Nephropathy in Diabetic eNOS Knockout Mice on Top of Angiotensin II Receptor Blockade
Ina M. Ott,Markus Alter,Karoline von Websky,Karoline von Websky,Axel Kretschmer,Oleg Tsuprykov,Oleg Tsuprykov,Yuliya Sharkovska,Katharina Krause-Relle,Katharina Krause-Relle,Jens Raila,Andrea Henze,Johannes-Peter Stasch,Johannes-Peter Stasch,Berthold Hocher,Berthold Hocher +15 more
TL;DR: In this article, the effects of the sGC stimulator riociguat and ARB telmisartan on kidney function and structure in a hypertensive model of diabetic nephropathy were investigated.